Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Lindestam Arlehamn, Cecilia S
Scriba, Thomas J
Cirillo, Daniela Maria
Denkinger, Claudia M
MetadataShow full item record
TitleCan we predict tuberculosis cure? What tools are available?
Published inEur Respir J 2018; 52(5): pii: 1801089
PubliekssamenvattingAntibiotic treatment of tuberculosis takes ≥6 months, putting a major burden on patients and health systems in large parts of the world. Treatment beyond 2 months is needed to prevent tuberculosis relapse by clearing remaining, drug-tolerant Mycobacterium tuberculosis bacilli. However, the majority of patients treated for only 2-3 months will cure without relapse and do not need prolonged treatment. Assays that can identify these patients at an early stage of treatment may significantly help reduce the treatment burden, while a test to identify those patients who will fail treatment may help target host-directed therapies.In this review we summarise the state of the art with regard to discovery of biomarkers that predict relapse-free cure for pulmonary tuberculosis. Positron emission tomography/computed tomography scanning to measure pulmonary inflammation enhances our understanding of "cure". Several microbiological and immunological markers seem promising; however, they still need a formal validation. In parallel, new research strategies are needed to generate reliable tests.
- Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure.
- Authors: Malherbe ST, Shenai S, Ronacher K, Loxton AG, Dolganov G, Kriel M, Van T, Chen RY, Warwick J, Via LE, Song T, Lee M, Schoolnik G, Tromp G, Alland D, Barry CE 3rd, Winter J, Walzl G, Catalysis TB–Biomarker Consortium., Lucas L, Spuy GV, Stanley K, Thiart L, Smith B, Du Plessis N, Beltran CG, Maasdorp E, Ellmann A, Choi H, Joh J, Dodd LE, Allwood B, Koegelenberg C, Vorster M, Griffith-Richards S
- Issue date: 2016 Oct
- Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy.
- Authors: Beltran CGG, Heunis T, Gallant J, Venter R, du Plessis N, Loxton AG, Trost M, Winter J, Malherbe ST, Kana BD, Walzl G
- Issue date: 2020
- [Is there a structural identity between sensitive strains of M. tuberculosis isolated from new patients and those from patients in recurrence and relapse following current initial chemotherapy?].
- Authors: Bercea O, Diaconescu C, Corlan E, Iacob L, Arjoceanu R, Ispas TL
- Issue date: 1987 Jul-Sep
- Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment.
- Authors: Cliff JM, Cho JE, Lee JS, Ronacher K, King EC, van Helden P, Walzl G, Dockrell HM
- Issue date: 2016 Feb 1
- Assessment of messenger RNA (mRNA) of Mycobacterium tuberculosis as a marker of cure in patients with pulmonary tuberculosis.
- Authors: Montenegro RA, Guarines KM, Montenegro LM, Lira LA, Falcão J, Melo FL, Santos FC, Nascimento AL, Zuzarte MS, Leite RC, Schindler HC
- Issue date: 2014 Jul